HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy

HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy

Objective HER-2 is overexpressed in a variety of human malignant tumors and has been widely used in the prognosis and treatment of breast cancer. In urothelial cell carcinoma of the bladder, some reports have shown an association between HER-2 overexpression and worse outcomes. The aim of this study...

Full description

Bibliographic Details
Main Authors: Georgios Moustakas, Spyridon Kampantais, Anastasia Nikolaidou, Ioannis Vakalopoulos, Valentini Tzioufa, Georgios Dimitriadis
Format: Article
Language:English
Published: SAGE Publishing 2020-01-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/0300060519895847

Similar Items

Similar Items